Skip to main content
. 2018 Jan 11;13(1):e0191231. doi: 10.1371/journal.pone.0191231

Table 1. Demographic data, comorbidity and tumor types of study participants.

DEMOGRAPHIC DATA AND COMORBIDITY ALL STUDY PARTICIPANTS
  Cancer patients (n = 60) Severely ill patients without known cancer (n = 51) p-value Healthy (n = 50)
Age, years (mean, SD) 70.4 (12.4) 76.7 (11.5) 0.059 68.1 (7.7)
Female (%) 58 57 0.556 58
Comorbidity Index Score* 3.3 ± 1.8 5.9 ± 2.1 <0.001 0
Comorbidity:        
Hypertension—no. (%) 18 (30) 34 (67) <0.001 13 (26)
Cerebrovascular disease—no. (%) 10 (17) 32 (63) <0.001 0
Congestive heart disease- no. (%) 6 (10) 10 (20) 0.122 0
Renal insufficiency- no. (%) 7 (12) 9 (18) 0.266 0
Liver failure- no. (%) 3 (5) 11 (22) 0.009 0
Diabetes mellitus type 1- no. (%) 0 (0) 11 (22) 0.209 0
Diabetes mellitus type 2- no. (%) 9 (15) 13 (25) 0.127 0
Chronic pulmonary disease- no. (%) 4 (7) 9 (18) 0.067 0
Dementia- no. (%) 0 (0) 8 (16) 0.001 0
Acute infection- no. (%) 6 (10) 7 (14) 0.376 0
TUMOR TYPES CANCER PATIENTS
Adenocarcinomas: No. (%) Localized (no.) Spread (no.)  
Breast 10 (17) 0 10  
Colorectal 11 (18) 0 11  
Stomach 2 (3) 0 2  
Biliary tract 2 (3) 0 2  
Peritoneum 2 (3) 1 1  
Lung 6 (10) 1 5  
Prostate 5 (8) 0 5  
Gynecological 4 (7) 0 4  
Pancreas 2 (3) 0 2  
Unknown origin 2 (3) 0 2  
Squamous cell carcinomas:        
Esophagus 1 (2) 0 1  
Lung 1 (2) 0 1  
Gingival 1 (2) 0 1  
Melanoma 3 (5) 0 3  
Glioblastoma 3 (5) 1 2  
Other** 5 (8) 3 2  

SD, standard deviation

* Comorbidity Index Score calculated from the Charlson Comorbidity Index (CCI).

** Other primary tumor types were neuroendocrine (N = 1), sarcoma (N = 1), liposarcoma, (N = 1), lymphoma (N = 1) and acute myeloid leukemia (N = 1). Fisher's exact test for categorical data; Mann-Whitney U test for continuous data.